Can-Fite BioPharma Ltd. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $5.98 per share for the 12-month period ending 2019-12-31, per its 6-K filed 2020-06-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2020-06-01
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2019-12-31 | $5.98 6-K · filed 2020-06-01 |
| 2018-12-31 | $7.53 6-K · filed 2020-06-01 |
| 2017-12-31 | $4.26 6-K · filed 2020-06-01 |